MONTREAL, Dec. 1 /CNW Telbec/ - GROUPE LAPERRIERE & VERREAULT INC. ("GL&V" or "the Company"; ticker symbols GLV.A, GLV.B/TSX) announces that between December 4 and 15, 2006, Messrs. Laurent Verreault, Chairman of the Board and Chief Executive Officer, Richard Verreault, President and Chief Operating Officer, Marc Barbeau, Vice-President and Co-Chief Financial Officer, and Mike Froud, Vice-President, Corporate Development, will give a series of corporate and financial presentations for investors in several Canadian and U.S. cities. The content of the presentation is available on the Company's website (www.glv.com).
About GL&V
----------
Founded in 1975, GL&V is a world leader in liquid/solid separation technologies used in a large number of industrial, municipal and environmental processes. The Process Group (Dorr-Oliver Eimco) offers an extensive selection of liquid/solid separation solutions intended for metal and minerals processing, as well as industrial and environmental processes used in various other markets such as pulp and paper, energy, chemicals, petrochemicals and food processing. The Pulp and Paper Group specializes in the design and marketing of equipment used in various stages of pulp and paper production, notably pulp preparation and sheet formation, and is a recognized leader in rebuilding, upgrading and optimization services for existing pulp and paper equipment. The Water Treatment Group (Eimco Water Technologies) specializes in the development and marketing of equipment for the treatment of municipal and industrial wastewater, drinking water and process water used in various industrial processes, as well as water intake screening solutions for power stations and refineries. Finally, an operating unit, GL&V Manufacturing, specializes in the production of large custom-made parts for external customers involved mainly in the pulp and paper and energy sectors, as well as GL&V's other units. GL&V is present in 40 countries on six continents and has approximately 2325 employees subsequent to the acquisition of Krebs International.
